CLDN12 and breast cancer: However, due to tissue-specific and tumor-specific regulatory mechanisms, decreased expression of CLDN12 predicts poor prognosis of cervical cancer50, Interleukin-18 (IL-18) promotes breast cancer cell migration by down-regulating CLDN12 and inducing P38/MAPK pathway51, etc.